Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Front Oncol. 2020 Nov 20:10:617539. doi: 10.3389/fonc.2020.617539. eCollection 2020.

Xiaoyi Hu^{1

2

3

4}, Mingyang Bao⁵, Jiacheng Huang^{1

2

3

4}, Lin Zhou^{2

3

4}, Shusen Zheng^{1

2

3

4}

¹ Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² National Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
³ Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, China.
⁴ Key Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
⁵ State Key Laboratory of Genetic Engineering, School of Life Sciences, Institute of Biostatistics, Fudan University, Shanghai, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.541479.].

Keywords: GEO; biomarker; diagnosis; hepatocellular carcinoma (HCC); prognosis.